Integrated pathway and epistasis analysis reveals interactive effect of genetic variants atTERF1andAFAP1L2loci on melanoma risk-Reference-Cited by-同舟云学术

Integrated pathway and epistasis analysis reveals interactive effect of genetic variants atTERF1andAFAP1L2loci on melanoma risk

Published:2015-05-26 Issue:8 Volume:137 Page:1901-1909
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brossard Myriam¹²,Fang Shenying³,Vaysse Amaury¹²,Wei Qingyi⁴,Chen Wei V.⁵,Mohamdi Hamida¹²,Maubec Eve¹²⁶,Lavielle Nolwenn¹²,Galan Pilar⁷,Lathrop Mark⁸,Avril Marie-Françoise⁹,Lee Jeffrey E.³,Amos Christopher I.¹⁰,Demenais Florence¹²

Affiliation:

1. INSERM; UMR-946, Genetic Variation and Human Diseases Unit; Paris France

2. Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité; Paris France

3. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX

4. Duke University Medical Center and Department of Medicine; Duke Cancer Institute; Duke University School of Medicine; Durham NC

5. Laboratory Informatics System, Department of Clinical Applications & Support; The University of Texas M. D. Anderson Cancer Center; Houston TX

6. AP-HP, Service de Dermatologie; Hôpital Bichat; Université Paris Diderot; Paris France

7. INSERM, UMR U557, Institut National de la Recherche Agronomique,U1125; Conservatoire National des arts et Métiers, Centre de Recherche en Nutrition Humaine; Ile de France Bobigny France

8. McGill University and Genome Quebec Innovation Centre; Montreal QC Canada

9. AP-HP, Hôpital Cochin et Université Paris Descartes; Paris France

10. Department of Community and Family Medicine; Geisel College of Medicine, Dartmouth College; Hanover NH

Funder

National Institutes of Health

National Cancer Institute

European Commission

Ligue Contre le Cancer

Fondation pour la Recherche Medicale

Institut National du Cancer

Marit Peterson Fund for Melanoma Research

Ministère de la Santé DHOS/ Programme Hospitalier de Recherche Clinique